SCHEMBL4453136

SCHEMBL4453136

CCc1cccc(C2=CCC(CC(=O)C=O)(OC)C=C2)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.36
PTGS2 P35354 1/20 0.34
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
THRB P10828 2/20 0.31
THRA P10827 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 2/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
ERN1 O75460 1/20 0.31
DHFR P00374 2/20 0.31
NISCH Q9Y2I1 1/20 0.30
MME P08473 1/20 0.30
MGLL Q99685 1/20 0.30
POLQ O75417 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4455027 0.77 BCL2 (0.39) BCL2PTGS2CYP4F2CYP4A11THRB
SCHEMBL4874423 0.68 MEP1B (0.32)
SCHEMBL27893814 0.64
SCHEMBL10715865 0.64
SCHEMBL27703664 0.62
SCHEMBL32679840 0.62 CHRM2 (0.32) SMN1; SMN2
SCHEMBL9489503 0.62
SCHEMBL18723855 0.62 CXCR3 (0.30)
SCHEMBL5984433 0.61 ALDH1A1 (0.36) KMT2AMAPT
SCHEMBL28872247 0.61 CACNA1F (0.39) THRBSMN1; SMN2LMNAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013176-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER Sterix Limited (GB) 2009-01-14 EP disclosed
WO-2007096647-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER STERIX LIMITED (GB) 2007-08-30 WO disclosed